Professional Documents
Culture Documents
Risk Assessment Considerations For Installation of A New Autoclave
Risk Assessment Considerations For Installation of A New Autoclave
Risk Assessment Considerations For Installation of A New Autoclave
ABSTRACT
This paper addresses some of the risk considerations that must be evaluated when replacing a steam sterilizing autoclave within a
pharmaceutical processing facility. It demonstrates the application of Failure Modes and Effects Analysis (FMEA) for assessment of
risk as part of quality risk management. Formal risk approaches normally share four basic concepts including risk assessment, risk
control, risk review, and risk communication. Risk management is fundamentally about understanding what is most important for the
control of equipment or design quality and then focusing resources on managing and controlling these aspects. Before risks can be
managed, they need to be assessed. FMEA is a widely used risk assessment tools. Steps to perform FMEA are identified; questions to
be asked are listed. Criteria for risk assessment must be defined. Either a numerical scoring system or marker phrases such as “high,”
“medium,” “low” may be utilized. Three areas are evaluated: Severity of the hazard, likelihood of occurrence, and likelihood of
detection. Tables for classifying these aspects are provided. A team approach to risk assessment is recommended. The risk
assessment process is demonstrated using the example of a steam sterilizing autoclave replacement.
INTRODUCTION
This paper addresses some of the risk considerations that must be evaluated when replacing a steam sterilization autoclave within a
pharmaceutical processing facility. A cast study format is utilized. In outlining the key risk considerations, the paper demonstrates a
risk assessment approach – Failure Modes and Effects Analysis (FMEA).
An autoclave is a pressure chamber used to sterilize equipment and supplies by subjecting them to high pressure saturated steam (1).
Autoclaves are used within pharmaceutical facilities to eliminate microbial cells and spores from within a given device. Autoclaves
commonly use steam heated to 115–134°C (250 273°F). To achieve sterility, a holding time of at least 30 minutes at 115°C, 15
minutes at 121°C (250°F) or 3 minutes at 134°C (273°F) is required (2).
The validation and verification of the sterilization process is well monitored in the pharmaceutical industry. Operators must ensure
that autoclaves comply with various regulatory guidances and regulations. Nonetheless, the purchase of a new autoclave and the
assessment requires evaluation. An additional dimension is added when one autoclave is being used to replace another, as with the
case study discussed here. To make such an evaluation, a formal risk assessment is required under the auspices of quality risk
management.
Risk management and risk assessment principles should be applied as early as possible during the design and construction of steam
sterilization devices. The most critical functions in a steam sterilization device are the steam sterilization of direct and indirect the
product contact parts. A second important aspect relates to air removal. All of the trapped air must be removed from the autoclave
before activation. Trapped air is a very poor medium for achieving sterility during the sterilization cycle.
Formal risk approaches normally share four basic concepts, which are listed below:
Risk assessment
Risk control
Risk review
Risk communication.
This paper considers the application of FMEA, failure modes and effects analysis, to the replacement of a steam-sterilizing autoclave
in a pharmaceutical manufacturing facility.
Three key definitions are outlined in ICH Q9(5). These help to contextualize what is meant by “risks.”
Risk: The combination of the probability of occurrence of harm and the severity of that harm
Harm: Damage to health, including the damage that can occur from loss of product quality or availability
Hazard: The potential source of harm.
For engineering systems, one of the most widely used tools for risk assessment is Failure Modes and Effects Analysis (FMEA) (6).
FMEA is a highly structured approach and can be undertaken through the following steps:
c) Setting scales for factors of severity, occurrence and detection (see below)
d) Process mapping
RISK CRITERIA
It is important to establish the risk assessment criteria as part of the risk assessment exercise. This is necessary in order to place risks
in proportion to one another and against a universal scale. Without this, it cannot be determined whether one risk is a greater or lesser
problem compared with another, or if a given risk could potentially result in patient harm.
FMEA may utilitze either a numerical scoring system or marker phrases such as “high,” “medium,” “low’ for quantitation. Marker
terms are used in the following case study.
These terms are applied to three aspects. These are the severity of the hazard; how likely the hazard is to occur; and whether there are
any mechanisms in place to detect the hazard should it occur. Here:
When these three are cross-compared, the overall risk can be established. The best means to do this is through the use of risk filters.
These are illustrated in Tables 1 and 2 below.
Before looking at the risk filter tables, it is necessary to define each of the terms used to establish the overall risk.
Severity of Impact
Likelihood of Occurrence
High = No Documentation
Medium = Incorrect Documentation
Low = Documentation present and correct
Probability of Detection
Risk Priority
Record the risk priority based upon the risk classification and probability of detection from the table.
Risk Process
In formulating the risk assessment a group was assembled consisting of engineering, validation, microbiology, and the end-users. The
process began by identifying the key risk factors and potential failure modes. These were described as “functional details.” Once
these were defined, these primary categories were broken down into sub-steps that are termed “sub-functional details.”
Once these were selected and agreed, the steps were grouped together. The group then proceeded to assess the risk for each step,
using the FMEA schema outlined above. This consisted of:
a) Considering the relevance of each sub-functional detail. For example, whether it could potentially impact upon product quality
b) The possible risk scenarios were considered
c) The severity of impact was then assessed as either “high”, “medium” or “low”, using the definitions outlined above
d) The likelihood of impact was then assessed, using the same descriptors
e) With the severity and likelihood assessed, the risk class was determined using Table 1 above.
f) The probability of detection was assessed next
g) Knowing the probability of detection allowed the overall risk priority to be determined using Table 2 above.
h) The penultimate step was to consider whether any controls or risk mitigation factors were in place
i) The final step was to reach a conclusion in relation to risk management.
The risk assessment process is outlined in Appendix I using the example of a steam sterilizing autoclave replacement.
Equipment preparation
The defined loading of the autoclave with equipment to be sterilized in an important sub-functional detail is in autoclave operation.
The relevance of loading an autoclave incorrectly significantly impacts product quality. Here the risk scenario is an incorrect
sterilization of the load. In this case:
The probability of detection would be low, because the activity is operator dependent and there are no system aspects that prevent an
incorrect load from being prepared. Therefore, using Table 2, the risk priority is high.
However, in terms of risk mitigation and risk management, a clear SOP can be put in place and operators can be trained in order to
lower the possibility of an incorrect load being prepared. In addition:
This example is included in Appendix I. Other sub-functional steps were derived using similar processes.
RISK EXAMPLE
Appendix I contains an example of risk assessment for a replacement steam-sterilizing autoclave. The table is arranged in a fashion to
facilitate the risk assessment steps described above where functional and sub-functional steps are outlined. The case study was
designed around a particular device and should be regarded as illustrative. Users embarking on a similar process may take note of the
items covered. However, they should construct their own risk schematic and reach conclusions that are relevant to their own
particular circumstances.
CONCLUSION
The final assessment of the FMEA risk exercise was that the new autoclave can be fitted and that the risks are adequately controlled.
It was noted that although the new autoclave has newer control systems technology, the steam sterilization principles together with the
load/ test cycles remain in line with the autoclave that is being replaced.
The FMEA risk assessment methodology was appropriate to the task. An alternative approach could have been to use a numerical risk
assessment. However, the use of descriptor words like “high,” “medium,” and “low” proved adequate in relation to the activity.
REFERENCES
1. Sandle, T. (2013). Sterility, Sterilisation and Sterility Assurance for Pharmaceuticals: Technology, Validation and Current
Regulations, Woodhead Publishing Ltd.: Cambridge, UK, pp93-110
2. Hugo WB (1991). A brief history of heat and chemical preservation and disinfection. J. Appl. Bacteriol. 71 (1): 9–18
3. Sandle, T. (2011): Risk Management in Pharmaceutical Microbiology. In Saghee, M.R., Sandle, T. and Tidswell, E.C. (Eds.)
(2011): Microbiology and Sterility Assurance in Pharmaceuticals and Medical Devices, New Delhi: Business Horizons,
pp553-588
4. Sandle, T. and Lamba, S. S. (2012) Effectively Incorporating Quality Risk Management into Quality Systems. In Saghee, M.R.
Achieving Quality and Compliance Excellence in Pharmaceuticals: A Master Class GMP Guide, New Delhi: Business
Horizons, pp89-128
5. ICH Q9: Quality risk management. International Conference on Harmonization of Technical Requirements for Registration
of Pharmaceuticals for Human Use ICH, Geneva (November 2005)
6. Sandle, T. (2003). The use of a risk assessment in the pharmaceutical industry – the application of FMEA to a sterility testing
isolator: a case study, European Journal of Parenteral and Pharmaceutical Sciences; 8(2): 43-49
FMEA KEY
BI - Biological Indicator
IQ - Installation Qualification
OQ - Operational Qualification
PQ - Performance Qualification
PC - Personal Computer
APPENDIX 1